5515-15-1

Basic information

• Product Name: METHOXY(4-NITROPHENYL)METHYLENE]PROPANEDINITRILE
• Synonyms: METHOXY(4-NITROPHENYL)METHYLENE]PROPANEDINITRILE
• CAS NO: 5515-15-1
• Molecular Formula: C₁₁H₇N₃O₃
• Molecular Weight: 229.194
• Mol File: 5515-15-1.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: METHOXY(4-NITROPHENYL)METHYLENE]PROPANEDINITRILE(CAS DataBase Reference)
• NIST Chemistry Reference: METHOXY(4-NITROPHENYL)METHYLENE]PROPANEDINITRILE(5515-15-1)
• EPA Substance Registry System: METHOXY(4-NITROPHENYL)METHYLENE]PROPANEDINITRILE(5515-15-1)

Safety Data

• Hazardous Substances Data: 5515-15-1(Hazardous Substances Data)

Upstream product

• 5515-11-7 2-[hydroxy(4-nitrophenyl)methylene]malononitrile 
• 77-78-1 dimethyl sulfate 
• 46700-35-0 (4-nitro-benzoyl)-malononitrile 
• 122-04-3 4-nitro-benzoyl chloride 
• 67-56-1 methanol 

Downstream Products

• 81067-03-0 2-Amino-4-methoxy-6-(4-nitro-phenyl)-pyrimidine-5-carbonitrile 
• 180903-11-1 5-amino-1-tert-butyl-3-(4-nitrophenyl)-1H-pyrazole-4-carbonitrile 
• 180903-18-8 AB₀₅₉ 
• 192512-78-0 C₁₆H₁₀N₆O₄ 
• 594983-83-2 5-amino-1-methyl-3-(4-nitrophenyl)-1H-pyrazole-4-carbonitrile 
• 42754-63-2 3-amino-5-(4-nitro-phenyl)-1⁽²⁾H-pyrazole-4-carbonitrile 
• 1446247-08-0 3-(4-nitrophenyl)-5-({[(3-pyrrolidin-1-ylpropyl)amino]carbonyl}amino)isothiazol-4-carboxamide 
• 1446247-10-4 3-(4-aminophenyl)-5-({[(3-pyrrolidin-1-ylpropyl)amino]carbonyl}amino)isothiazol-4-carboxamide 
• 1446247-11-5 3-[4-({[(4-methylphenyl)amino]carbonyl}amino)phenyl]-5-({[(3-pyrrolidin-1-ylpropyl)amino]carbonyl}amino)isothiazol-4-carboxamide 
• 605661-26-5 2-[amino(4-nitrophenyl)methylene]malononitrile 
• 909028-96-2 3-amino-3-(4-nitrophenyl)-2-thioformamidoacrylonitrile 
• 1446247-91-1 C₂₄H₂₆N₆O₅S 
• 1446247-90-0 C₁₆H₁₇N₅O₆S 
• 605661-28-7 5-amino-3-(4-nitrophenyl)isothiazole-4-carbonitrile 

Relevant articles and documents

3-PHENYL-5-UREIDOISOTHIAZOLE-4-CARBOXIMIDE AND 3-AMINO-5-PHENYLISOTHIAZOLE DERIVATIVES AS KINASE INHIBITORS

This invention is directed to a compound of Formula I Formula I or a pharmaceutically acceptable salt thereof, wherein R, R1, R2, R3, n, X1, X2, L1, and L2 are as defined herein.

FUSED RING HETEROARYL KINASE INHIBITORS

Provided herein are fused ring heteroaryl compounds useful in a variety of methods, including reducing the activity of certain kinases and treating certain disease states.

CHEMICAL COMPOUNDS

Pyrazole derivatives are described herein. The described invention also includes methods of making such pyrazole derivatives as well as methods of using the same in the treatment of diseases.